Generics Industry Prescribes Remedies For EU Regulatory Sprawl
This article was originally published in Scrip
Executive Summary
Over the 50 years that the EU pharmaceutical legislation has been in place, great progress has been made in terms of improving the quality, safety and efficacy of medicines, and a significant effort has been expended in building a strong European regulatory structure and harmonized European standards.
You may also be interested in...
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.